M1 macrophages promote aortic valve calcification mediated by microRNA-214/TWIST1 pathway in valvular interstitial

Xiao-Fei Li1, Yan Wang1, Dong-Dong Zheng1

  • 1Department of Cardiology, Affiliated Hospital of Nantong University Nantong 226001, China.

Abstract

Insights

M1 macrophages promote aortic valve calcification (AVC) by transferring miR-214 via microvesicles, downregulating TWIST1 in valvular interstitial cells. Inhibiting miR-214 may offer a therapeutic strategy for AVC.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Aortic valve calcification (AVC) is a progressive disease.
  • Valvular interstitial cells (VICs) play a key role in AVC pathogenesis.
  • Macrophage polarization, particularly M1 phenotype, is implicated in inflammatory processes contributing to AVC.

Purpose of the Study:

  • To investigate the mechanism by which M1 macrophages and their derived microvesicles (MVs) influence VIC calcification.
  • To elucidate the role of the miR-214 pathway in M1 macrophage-mediated VIC calcification.
  • To evaluate the therapeutic potential of targeting the miR-214 pathway for AVC prevention.

Main Methods:

  • Analysis of macrophage polarization markers in human calcific aortic valves.
  • In vitro co-culture of M1 macrophages and their MVs with VICs.
  • Gene expression analysis of TWIST1 and miR-214.
  • In vivo studies using a hypercholesterolemic apoE-/- mouse model of AVC.
  • Therapeutic intervention with miR-214 specific-siRNA.

Main Results:

  • Macrophages in calcific aortic valves exhibited M1 polarization.
  • M1 macrophages and their MVs enhanced VIC calcification in vitro.
  • miR-214 delivered by MVs downregulated TWIST1 expression in VICs, promoting calcification.
  • Knockdown of miR-214 in vivo showed a trend towards improving AVC in a mouse model.

Conclusions:

  • M1 macrophages promote AVC by delivering miR-214 to VICs via MVs, leading to TWIST1 downregulation.
  • The miR-214/TWIST1 axis is a key mediator of M1 macrophage-induced VIC calcification.
  • Targeting the miR-214 pathway represents a potential therapeutic strategy for AVC.